文献速递脑血管病外科功能神经外科

以三叉神经痛为首发症状的脑桥周围动静脉畸形患者的管理结局

Management outcomes of peripontine arteriovenous malformation patients presenting with trigeminal neuralgia.
PubMed 文献 · J Neurosurg · 2023-07-14

该回顾性队列研究分析了本机构脑桥周围动静脉畸形(bAVM)数据库,发现57例中8例(14.0%)以同侧三叉神经痛(TN)为首发表现。6例(75%)接受放射外科治疗,全部TN症状完全缓解,83.3%的畸形血管团闭塞。作者认为放射外科可安全有效实现持久TN控制。

要点

  • 以TN为首发症状的脑桥周围bAVM罕见,57例中仅8例(14.0%)。
  • TN相关bAVM均未破裂出血,非TN相关bAVM有25例(51%)出血(p < 0.01)。
  • 6例(75%)接受放射外科治疗,TN全部完全缓解,83.3%畸形血管团闭塞。

核心结论

  • TN相关bAVM罕见,管理证据有限;放射外科可安全有效实现持久TN控制,尽管位置深且未破裂,放射外科后闭塞率可达83.3%。

研究设计与样本

  • 回顾性队列研究,查询本机构bAVM数据库,纳入脑桥、脑池、脑干、三叉神经或小脑幕部位的非遗传性出血性毛细血管扩张症bAVM,筛选以同侧TN或「面部疼痛」为首发症状且数据完整的患者。

主要发现

  • 57例脑桥周围bAVM中8例(14.0%)因同侧TN被发现,其中4例(50%)面部疼痛位于V2分布区。
  • 5例(62.5%)初始药物治疗为卡马西平,2例(25%)接受多次神经根切断术,1例(12.5%)接受微血管减压术。
  • TN相关bAVM均无出血表现,非TN相关bAVM有25例(51%)出血(p < 0.01)。
  • TN相关bAVM总体小于非TN相关bAVM,但差异无统计学意义(1.71 cm vs 2.22 cm,p = 0.117),Spetzler-Martin分级相似。
  • 6例(75%)接受放射外科治疗(平均剂量1800 cGy,平均靶体积0.563 cm3),TN症状完全缓解(100%),平均缓解时间193天(范围21-360天),83.3%治疗侧bAVM闭塞;2例(12.5%)建议保守管理,其中1例后续接受神经根切断术,另1例随访期间死于出血。

关键数值与推荐

  • TN相关bAVM平均大小1.71 cm vs 非TN相关bAVM 2.22 cm(p = 0.117)。
  • 放射外科平均剂量1800 cGy,平均靶体积0.563 cm3;TN完全缓解率100%,平均缓解时间193天(范围21-360天),闭塞率83.3%。

临床怎么用

  • 作者认为放射外科可安全有效实现TN相关bAVM患者的持久TN控制。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Trigeminal neuralgia as the presenting symptom of brain arteriovenous malformation (bAVM) has been rarely reported. Treatment of reported cases has been skewed toward surgery for these scarce, deeply located bAVMs. Here, the authors report their management and outcomes of bAVM patients presenting with ipsilateral trigeminal neuralgia (TN) at their institution. METHODS: This is a retrospective cohort study. The authors' institutional bAVM database was queried for non-hereditary hemorrhagic telangiectasia bAVMs in pontine, cistern, brainstem, trigeminal nerve, or tentorial locations. Patients with complete data were included in a search for trigeminal neuralgia or "facial pain" as the presenting symptom with TN being on the same side as the bAVM. Demographics, TN and bAVM characteristics, management strategies, and outcomes of bAVM and TN management were analyzed. RESULTS: Fifty-seven peripontine bAVMs were identified; 8 (14.0%) of these bAVMs were discovered because of ipsilateral TN, including 4 patients (50%) with facial pain in the V2 distribution. Five patients (62.5%) were treated with carbamazepine as the initial medical therapy, 2 (25%) underwent multiple rhizotomies, and 1 (12.5%) underwent microvascular decompression. None of the patients with TN-associated bAVMs presented with hemorrhage, compared with 25 patients (51%) with bAVMs that were not associated with TN (p < 0.01). TN-associated bAVMs were overall smaller than non-TN-associated bAVMs, but the difference was not statistically significant (1.71 cm vs 2.22 cm, p = 0.117), and the Spetzler-Martin grades were similar. Six patients (75%) underwent radiosurgery to the bAVM (mean dose 1800 cGy, mean target volume 0.563 cm3) and had complete resolution of TN symptoms (100%). The mean time from radiosurgery to TN resolution was 193 (range 21-360) days, and 83.3% of treated TN-associated bAVMs were obliterated via radiosurgery. Two patients (12.5%) were recommended for conservative management, with one undergoing subsequent rhizotomies and another patient died of hemorrhage during follow-up. CONCLUSIONS: TN-associated bAVM is a rare condition with limited evidence for management guidance. Radiosurgery can be safe and effective in achieving durable TN control in patients with TN-associated bAVMs. Despite their deep location and unruptured presentation, obliteration can reach 83.3% with radiosurgery.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Yang W, Sattari SA, Feghali J, et al. Management outcomes of peripontine arteriovenous malformation patients presenting with trigeminal neuralgia. J Neurosurg. 2023. PMID: 37486910. doi:10.3171/2023.5.JNS23771

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。